Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2116
mi
from 91732
Dunedin, FL
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2116
mi
from 91732
Dunedin, FL
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1335
mi
from 91732
Overland Park, KA
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1335
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1813
mi
from 91732
Louisville, KY
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1813
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2258
mi
from 91732
Frederick, MD
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2258
mi
from 91732
Frederick, MD
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1894
mi
from 91732
Lansing, MI
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1894
mi
from 91732
Lansing, MI
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1254
mi
from 91732
Lincoln, NE
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1254
mi
from 91732
Lincoln, NE
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from 91732
Orchard Park, NY
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from 91732
Orchard Park, NY
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1259
mi
from 91732
Bismarck, ND
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1259
mi
from 91732
Bismarck, ND
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1897
mi
from 91732
Dayton, OH
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2200
mi
from 91732
Duncansville, PA
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2200
mi
from 91732
Duncansville, PA
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2331
mi
from 91732
Wyomissing, PA
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2331
mi
from 91732
Wyomissing, PA
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2184
mi
from 91732
Charleston, SC
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1859
mi
from 91732
Hixson, TN
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1859
mi
from 91732
Hixson, TN
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1213
mi
from 91732
Austin, TX
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1213
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2102
mi
from 91732
Clarksburg, WV
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2102
mi
from 91732
Clarksburg, WV
Click here to add this to my saved trials
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated:  12/31/1969
Research Site
1029
mi
from 91732
Victoria,
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept
Status: Enrolling
Updated: 12/31/1969
Research Site
1029
mi
from 91732
Victoria,
Click here to add this to my saved trials
Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After Surgery
Total vs. Reverse Shoulder Replacement: a Prospective Randomized Trial
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After Surgery
Total vs. Reverse Shoulder Replacement: a Prospective Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Arizona Arthritis and Rheumatology Research
336
mi
from 91732
Glendale, AZ
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arizona Arthritis and Rheumatology Research
336
mi
from 91732
Glendale, AZ
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Arizona Arthritis & Rheumatology Associates, P. C.
355
mi
from 91732
Mesa, AZ
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arizona Arthritis & Rheumatology Associates, P. C.
355
mi
from 91732
Mesa, AZ
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Sun Valley Arthritis Center, Ltd
333
mi
from 91732
Peoria, AZ
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Sun Valley Arthritis Center, Ltd
333
mi
from 91732
Peoria, AZ
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Valley Arthritis Care, LLC
343
mi
from 91732
Phoenix, AZ
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Valley Arthritis Care, LLC
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Arizona
427
mi
from 91732
Tucson, AZ
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Arizona
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Valley Endocrine, Fresno
216
mi
from 91732
Fresno, CA
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Valley Endocrine, Fresno
216
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Allergy and Rheumatology Medical Clinic Inc
95
mi
from 91732
La Jolla, CA
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Allergy and Rheumatology Medical Clinic Inc
95
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Desert Medical Advances
96
mi
from 91732
Palm Desert, CA
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Desert Medical Advances
96
mi
from 91732
Palm Desert, CA
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Stanford University Hospital
328
mi
from 91732
Palo Alto, CA
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Stanford University Hospital
328
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Pacific Arthritis Center
32
mi
from 91732
Santa Maria, CA
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Pacific Arthritis Center
32
mi
from 91732
Santa Maria, CA
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Inlande Rheumatology Clinical Trials
20
mi
from 91732
Upland, CA
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Inlande Rheumatology Clinical Trials
20
mi
from 91732
Upland, CA
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Boulder Medical Center
812
mi
from 91732
Boulder, CO
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Boulder Medical Center
812
mi
from 91732
Boulder, CO
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Denver Arthritis Center
822
mi
from 91732
Denver, CO
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Denver Arthritis Center
822
mi
from 91732
Denver, CO
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of CT/NY
2458
mi
from 91732
Danbury, CT
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of CT/NY
2458
mi
from 91732
Danbury, CT
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
New England Research Associates, Llc
2471
mi
from 91732
Trumbull, CT
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
New England Research Associates, Llc
2471
mi
from 91732
Trumbull, CT
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Delaware Arthritis
2383
mi
from 91732
Lewes, DE
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Delaware Arthritis
2383
mi
from 91732
Lewes, DE
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Orthopedic Research Institute
2309
mi
from 91732
Boynton Beach, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Orthopedic Research Institute
2309
mi
from 91732
Boynton Beach, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Jeffrey Alper, MD Research
2220
mi
from 91732
Naples, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Jeffrey Alper, MD Research
2220
mi
from 91732
Naples, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Sun Coast Clinical Research, Inc
2114
mi
from 91732
New Port Richey, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Sun Coast Clinical Research, Inc
2114
mi
from 91732
New Port Richey, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Omega Research Consultants, Llc
2182
mi
from 91732
Orlando, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Omega Research Consultants, Llc
2182
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Rheumatology Associates of Central Florida
2185
mi
from 91732
Orlando, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Rheumatology Associates of Central Florida
2185
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Arthritis Research of Florida, Inc.
2117
mi
from 91732
Palm Harbor, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arthritis Research of Florida, Inc.
2117
mi
from 91732
Palm Harbor, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
West Broward Rheumatology Associates, Inc.
2306
mi
from 91732
Tamarac, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
West Broward Rheumatology Associates, Inc.
2306
mi
from 91732
Tamarac, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
McIlwain Medical Group
2132
mi
from 91732
Tampa, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
McIlwain Medical Group
2132
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Tampa Medical Group, PA
2132
mi
from 91732
Tampa, FL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Tampa Medical Group, PA
2132
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Intermountain Research Center
666
mi
from 91732
Boise, ID
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Intermountain Research Center
666
mi
from 91732
Boise, ID
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Deerbrook Medical Associates
1716
mi
from 91732
Vernon Hills, IL
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Deerbrook Medical Associates
1716
mi
from 91732
Vernon Hills, IL
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Indiana University Health
1793
mi
from 91732
Indianapolis, IN
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Indiana University Health
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Diagnostic Rheumatology and Research PC
1793
mi
from 91732
Indianapolis, IN
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Diagnostic Rheumatology and Research PC
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Goldpoint Clinical Research
1792
mi
from 91732
Indianapolis, IN
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Goldpoint Clinical Research
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials